Skip to main content

Bispectral index monitoring reduces sedative and vasopressor requirements during percutaneous tracheostomy

Introduction

Bispectral index (BIS) monitoring measures depth of anaesthesia, using electroencephalography (EEG). It has been validated against sedation scales used in intensive care. We hypothesized that using BIS during percutaneous tracheostomies would reduce sedation doses, resulting in fewer episodes of haemodynamic instability.

Methods

Patients undergoing percutaneous tracheostomy were randomised to the control or intervention groups. Norepinephrine was administered to prevent a fall of more than 20% in mean arterial blood pressure. Patients in the control group were sedated with a propofol infusion at a dose chosen by the operator. All personnel performing the tracheostomy were blinded to the BIS score. In the intervention group, patients were sedated with a propofol infusion adjusted so that the BIS was maintained between 45 and 60. Patients with encephalopathy or brain injury, and patients who had received sedative drugs other than alfentanil and propofol were excluded. All patients or their advocates gave written, informed consent. The primary outcome was the number of episodes of haemodynamic instability. Secondary outcomes were the dose of propofol administered to patients, BIS scores, time of recovery from sedation, total norepinephrine administered to patients, and time taken to do the procedure.

Results

Twenty patients entered the study. Results are presented as mean ± SD. There was no significant difference in the incidence of hypotension (4.5 ± 6.8 events and 5.6 ± 6.9 events in control and intervention groups, respectively, P = 0.25). There were fewer episodes of hypertension in the intervention group (2.5 ± 4.6 events in the control group and 0.9 ± 2.2 events in the intervention group) (P = 0.12). The dose of propofol and norepinephrine dose were lower in the intervention group: 5.4 mg/kg/hour cf. to 6.8 mg/kg/hour for propofol (P = 0.21); 0.05 μg/kg/hour cf. to 0.09 μg/kg/hour for norepinephrine (P = 0.14). The mean time to waking was significantly shorter in the intervention group (54 minutes) as compared with that in the control group (96 minutes), P = 0.04.

Conclusions

BIS monitoring did not significantly reduce sedation requirements, or improve haemodynamics during percutaneous tracheostomy, although there was a trend to both reduced sedation requirements and improved haemodynamic stability. The time to waking was significantly reduced.

Author information

Affiliations

Authors

Corresponding author

Correspondence to P Hampshire.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Hampshire, P., Guha, A., Welters, I. et al. Bispectral index monitoring reduces sedative and vasopressor requirements during percutaneous tracheostomy. Crit Care 15, P348 (2011). https://doi.org/10.1186/cc9768

Download citation

Keywords

  • Intervention Group
  • Norepinephrine
  • Alfentanil
  • Bispectral Index
  • Sedative Drug